Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Phase II Study of Sorafenib (BAY43-9006) in Non-GIST Sarcomas

NCT00245102 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00245102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00245102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Phase II Study of Sorafenib (BAY43-9006) in Non-GIST Sarcomas
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2005
Completion date
March 31, 2011
Enrollment
147 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult angiosarcoma, adult epithelioid sarcoma, adult leiomyosarcoma, adult malignant fibrous histiocytoma, adult neurofibrosarcoma, adult synovial sarcoma, ovarian sarcoma, recurrent adult soft tissue sarcoma, recurrent uterine sarcoma, stage iii adult soft tissue sarcoma, stage iii uterine sarcoma, stage iv adult soft tissue sarcoma, stage iv uterine sarcoma, uterine carcinosarcoma, uterine leiomyosarcoma